Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Regulatory News (EML)

Share Price Information for Emmerson (EML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.95
Bid: 1.90
Ask: 2.00
Change: 0.05 (2.63%)
Spread: 0.10 (5.263%)
Open: 1.90
High: 1.95
Low: 1.90
Prev. Close: 1.90
EML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Phased Development and Expansion Assessment

17 Feb 2021 07:00

RNS Number : 3998P
Emmerson PLC
17 February 2021
 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

 

17 February 2021

Emmerson Plc

("Emmerson" or "the Company")

Emmerson to Examine Phased Development and Expansion Projects for theWorld Class Khemisset Potash Project

 

Emmerson Plc, the Moroccan focused potash development company, is pleased to announce that it is in the process of assessing a conceptual, staged, development for its 100% owned Khemisset Potash Project ("Khemisset" or "the Project"), aimed at reducing upfront capital costs and incorporating expansion options into the development plan of the Project. Emmerson recently received the Mining Licence (see RNS dated 9 February 2021) for Khemisset providing the Company with the exclusive right to develop and mine the potash deposit, in the Khemisset basin ahead of the anticipated initiation of construction by the end of 2021.

 

To view the RNS with illustrative diagrams, please use the following link: http://www.rns-pdf.londonstockexchange.com/rns/3998P_1-2021-2-17.pdf

 

· Updated development strategy to fast-track salt sales expansion, SOP development and MOP expansion utilising the total resource at Khemisset

o Increase salt sales to up to 4Mtpa

o Incorporate SOP as part of the larger project development

o Increase MOP production by up to 50%

o Increase mine life

· Additional potential benefits include reduced financing and execution risk; operating cost, sales, marketing and logistics synergies; and increased diversification of product revenues

· Khemisset Mining Licence puts Emmerson in position to commence construction during 2021, finance permitting

 

Graham Clarke, Emmerson's CEO, commented:

"Khemisset is a project of enormous potential and we see several opportunities to improve upon the mine plan presented in the 2020 Feasibility Study. The most obvious is the potential to expand the Project, given it is currently based on less than 50% of our total Mineral Resource Estimate.

 

"We have also previously discussed the potential to increase our salt sales and our ongoing investigations into the global de-icing salt market and, in particular, the US market gives us a high level of confidence in our ability to upscale our salt production significantly.

 

"We have previously presented a Scoping Study for an SOP project which indicated a project that could deliver an additional US$70m of EBITDA for the Company for minimal capital expenditure. The SOP market, especially our target US sales market, continues to show strength in pricing, which drives a strategy to accelerate the development of that project, which provides increased cashflow generation, but also diversity of end-product.

 

"Finally, the capital cost benefits of our project mean that we believe we can develop our project using a staged approach, which reduces upfront capital costs and equity requirements from the market and, therefore, dilution to our existing shareholders as we grow to our full potential.

 

"With our mining licence in hand, we see 2021 as a pivotal year for our development as we aim to become the only potash producer in Africa and the only independent potash producer globally."

 

Overview of Work Programmes

Building on the Feasibility Study (refer announcement 1 June 2020), the Company will complete a concept study examining the potential to develop Khemisset using a stage approach, reducing upfront capital costs and execution risk, while also planning out additional stages of expansion for the Project to ensure that its economic value is fully developed.

 

 

Figure 1: Conceptual View of the Staged Development and Expansion Strategy

 

Due to the relatively lower levels of fixed capital cost, the Company believes that Khemisset could benefit from a staged development approach. The Company will examine the technical and economic viability of initially constructing a project that mines at approximately half the rate assumed in the Feasibility Study. This could materially reduce the upfront capital cost of the Project, lowering financing and execution risk. Following this phase 1 development the project will then run through several expansion phases.

 

During the Feasibility Study, the Company confirmed its ability to manufacture significant quantities of de-icing salt and designed the Project to produce 1Mtpa for sale into the US market. Following the completion of the Feasibility Study, Emmerson has continued to assess the market opportunity for de-icing salt and has concluded that there is likely to be a much larger market opportunity for this product. The Company intends to scope the cost to increase salt sales to up to 4Mtpa.

 

In November 2019, the Company completed a Scoping Study to assess the viability of converting 25% of its MOP to produce 240ktpa of SOP. With the continuing strength of the US SOP market, the Company is looking to accelerate the development of the SOP Project to take advantage of this strength and to improve diversity of end product and revenue.

 

Finally, the Feasibility Study was based on only 43% of the total Mineral Resource Estimate for the Project. Clearly, the remaining resource presents significant incremental value to the Project and the Company intends to design in an expansion project to increase production by up to 50%. This will materially improve cashflow over the life of the Project and improve the already outstanding economics.

**ENDS**

 

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact: 

 

Graham Clarke

 

Emmerson plc

+44 (0) 207 236 1177 

 

Jerry Keen

Toby Gibbs

John More

 

 

Shore Capital

 

 

+44 (0)20 7408 4090 

 

 

 

Damon Heath

Isabella Pierre

Shard Capital

+44 (0) 207 628 3396

 

Megan Dennison

Susie Geliher

 

St Brides Partners Limited

Financial PR/IR

 

+44 (0)20 7236 1177

 

 

Notes to Editors

Emmerson's primary focus is on developing the Project located in Northern Morocco. The Project has a large JORC Resource Estimate (2012) of 537Mt @ 9.24% K2O and significant exploration potential with an accelerated development pathway targeting a low capex, high margin mine. Khemisset is perfectly located to capitalise on the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. This unique positioning means the Project will receive a premium netback price compared to existing potash producers. The need to feed the world's rapidly increasing population is driving demand for potash and Emmerson is well placed to benefit from the opportunities this presents. The Feasibility Study released in June 2020 indicated Khemisset has the potential to be among the lowest capital cost development stage potash projects in the world and also, as a result of its location, one of the highest margin projects. This delivered outstanding economics including a post-tax NPV8 of approximately US$1.4 billion using industry expert, Argus', price forecasts.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGLGDDISBDGBR
Date   Source Headline
24th May 20247:00 amRNS2023 Financial Results
22nd Apr 202411:47 amRNSTR-1: Notification of major holdings
8th Apr 20244:45 pmRNSResults of Oversubscribed REX Retail Offer
8th Apr 20247:01 amRNSREX Retail Offer
8th Apr 20247:00 amRNSQ1 Update, Equity Placing and Retail Offer
11th Mar 20247:00 amRNSCommittee Upholds Environmental Approval Referral
1st Feb 20247:00 amRNSScoping Study on Breakthrough New Processing Route
8th Jan 20247:00 amRNSQ4 Update
21st Dec 20237:00 amRNSExtension of Mandated Lead Arrangers
26th Sep 20237:00 amRNSInterim Results for the six months to 30 June 2023
21st Sep 20237:00 amRNSQ3 2023 and Financing update
11th Sep 202311:38 amRNSMorocco Statement
11th Jul 202311:57 amRNSDirector/PDMR Shareholding
10th Jul 20234:30 pmRNSDirector/PDMR Shareholding
6th Jul 20232:49 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSQ2 Update
6th Jun 20237:00 amRNSExercise & Allotment of Shares
31st May 202312:01 pmRNSResult of AGM
5th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20237:00 amRNS2022 Financial Results and Q1 Update
14th Feb 20237:00 amRNSMandated Lead Arrangers Appointed for Financing
9th Jan 20237:00 amRNSQ4 Update
3rd Jan 20237:00 amRNSAppointment of Liberum as Nominated Advisor
21st Nov 20227:00 amRNSPotash and Salt Offtake MOUs
27th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20221:45 pmRNSResults of REX Retail Offer & Total Voting Rights
26th Sep 20227:02 amRNSREX Retail Offer
26th Sep 20227:01 amRNSRenewal of Strategic Investment & Equity Placing
26th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
16th Aug 20224:18 pmRNSExercise of Options & Director/PDMR Shareholding
22nd Jul 20229:00 amRNSShare Options Scheme & Director Shareholdings
19th Jul 20225:05 pmRNSReplacement: Director/PDMR Shareholding
18th Jul 20224:00 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSQ2 Activities Update
7th Jul 202212:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSExercise of Warrants and Issue of Shares
13th Jun 20227:00 amRNSNotice of AGM and Posting of Annual Report
31st May 20227:00 amRNSAudited Results for the year ended 31 Dec 2021
31st Mar 20227:00 amRNSQ1 Activities Update
15th Mar 20227:00 amRNSGrant of Share Options
21st Feb 20227:00 amRNSAppointment of Chief Financial Officer
16th Feb 20227:00 amRNSAppointment of Corporate Broker
27th Jan 20227:00 amRNSBasic Engineering Packages Awarded to Reminex S.A
25th Jan 20221:00 pmRNSPart Exercise of Options and Issue of Shares
31st Dec 20217:00 amRNSEnd of Year Newsletter
6th Dec 202112:45 pmRNSResult of AGM
6th Dec 202112:31 pmRNSResult of General Meeting
2nd Dec 20217:00 amRNSOperational Update: Khemisset Potash Project
29th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSIssue of Equity & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.